PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How does Xofigo treat advanced prostate cancer?

ANSWER

Xofigo is approved for use in men who have advanced prostate cancer that has spread only to the bones. Candidates should have also received androgen deprivation therapy. Xofigo, given by injection once a month, works by binding to minerals within bones to deliver radiation directly to bone tumors. A study of 809 men showed that those taking Xofigo lived an average of three months longer than those taking a placebo.

SOURCES: 

Prostate Cancer Foundation. 

National Institutes of Health.

American Cancer Society web site.

News release, Astellas Pharma Inc.

Reviewed by William Blahd on July 11, 2017

SOURCES: 

Prostate Cancer Foundation. 

National Institutes of Health.

American Cancer Society web site.

News release, Astellas Pharma Inc.

Reviewed by William Blahd on July 11, 2017

NEXT QUESTION:

How can external beam radiation therapy treat advanced prostate cancer?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: